Edwards Lifesciences

By person

18 insiders · 54 transactions

7.9×

Mr. Zovighian holds 7.9 times base salary in stock. $9.43M of shares against $1.19M in salary for 2025.

Salary from the company's own proxy. The shares are what Mr. Zovighian last reported holding, valued at $87.51, the price Common Stock was last bought or sold at on the open market here, on 11 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

BOBO DONALD E JR

CVP,Strategy/Corp Development

—

$11.15M (12)

−$11.15M

121,409

0.0211%

$10.62M

−36.2%

Zovighian Bernard J

CEO

—

$7.00M (8) scheduled

−$7.00M

107,761

0.0187%

$9.43M

+56.6%

Ullem Scott B.

CVP, Chief Financial Officer

—

$3.87M (7) scheduled

−$3.87M

46,740

0.0081%

$4.09M

+52.9%

Chopra Daveen

CVP, TMTT, Surgical & IHFM

—

$3.19M (4) scheduled

−$3.19M

43,926

0.0076%

$3.84M

+49.7%

Markowitz Wayne

CVP, JAPAC

—

$1.04M (5) scheduled

−$1.04M

19,371

0.0034%

$1.70M

+90.2%

Lippis Daniel J.

CVP, TAVR

—

$871.62K (13) scheduled

−$871.62K

40,034

0.0069%

$3.50M

+69.9%

Bruls Annette

CVP, EMEACLA

—

$237.91K (1)

−$237.91K

17,984

0.0031%

$1.57M

+122.6%

STONE HEISZ LESLIE

Director

—

$218.12K (1)

−$218.12K

34,199

0.0059%

$2.99M

+13.9%

Dahl Andrew M.

SVP, Corporate Controller

—

$98.39K (2)

−$98.39K

14,615

0.0025%

$1.28M

+171.5%

Wood Larry L

Global President TAVR & Surg

—

206,900

0.0359%

$18.11M

−7.5%

Mistras Theodora

CVP, Chief Financial Officer

—

99,920

0.0173%

$8.74M

—

VALERIANI NICHOLAS J

Director

—

84,423

0.0146%

$7.39M

+14.5%

LAVIOLETTE PAUL A

Director

—

17,552

0.0030%

$1.54M

+62.9%

Davis Leslie C.

Director

—

9,834

0.0017%

$860.57K

+221.9%

Feinberg David T

Director

—

9,087

0.0016%

$795.20K

+293.7%

LORANGER STEVEN R

Director

—

8,997

0.0016%

$787.33K

—

Sequeira Ramona

Director

—

6,779

0.0012%

$593.23K

—

GALLAHUE KIERAN

Director

—

4,315

0.0007%

$377.61K

—

By person

Individual transactions

What was left out